,Set,NGenes,Direction,PValue,FDR
1,WP_CYTOPLASMIC_RIBOSOMAL_PROTEINS,86,Up,1.48931740953766e-09,1.22421891063996e-06
2,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3,7,Up,1.84597827681888e-05,0.00758697071772558
3,WP_GLP1_SECRETION_FROM_INTESTINE_TO_PORTAL_VEIN,1,Down,6.69752184742928e-05,0.0161445578172837
4,WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY,19,Down,7.85623251449327e-05,0.0161445578172837
5,WP_BIOSYNTHESIS_AND_TURNOVER_OF_1DEOXYSPHINGOID_BASES,6,Down,0.000108430404779216,0.0178259585457031
6,WP_OLIGODENDROCYTE_SPECIFICATION_AND_DIFFERENTIATION_LEADING_TO_MYELIN_COMPONENTS_FOR_CNS,7,Down,0.000145272692651468,0.0195857610474449
7,WP_SPHINGOLIPID_METABOLISM_OVERVIEW,19,Down,0.000166788719382135,0.0195857610474449
8,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_1,7,Up,0.000281529629766814,0.0257130395187024
9,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_5,7,Up,0.000281529629766814,0.0257130395187024
10,WP_AIRWAY_SMOOTH_MUSCLE_CELL_CONTRACTION,10,Down,0.000618670590229165,0.0508547225168374
11,WP_SPHINGOLIPID_PATHWAY,20,Down,0.00124956835099794,0.0933768349563914
12,WP_STATIN_INHIBITION_OF_CHOLESTEROL_PRODUCTION,15,Up,0.00158516225886275,0.108583614732098
13,WP_INFLAMMATORY_RESPONSE_PATHWAY,14,Up,0.00203182258546428,0.120220500340513
14,WP_SYNTHESIS_OF_CERAMIDES_AND_1DEOXYCERAMIDES,14,Down,0.00204755110069001,0.120220500340513
15,WP_COMPLEMENT_ACTIVATION,12,Up,0.00331082010357163,0.173761557728939
16,WP_SPINAL_CORD_INJURY,63,Down,0.00338222010177983,0.173761557728939
17,WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE,18,Down,0.00397748607325838,0.182884481312003
18,WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY,10,Up,0.00421397558305734,0.182884481312003
19,WP_COVID19_ADVERSE_OUTCOME_PATHWAY,7,Down,0.00462107660701657,0.182884481312003
20,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_2,5,Up,0.00484141146015559,0.182884481312003
21,WP_TYROBP_CAUSAL_NETWORK_IN_MICROGLIA,56,Up,0.00484402473194439,0.182884481312003
22,WP_COMPLEMENTMEDIATED_INFLAMMATION_OF_PULMONARY_ALVEOLUS_IN_COVID19_HYPOTHETICAL_PATHWAY,6,Up,0.00489471847793682,0.182884481312003
23,WP_EXERCISEINDUCED_CIRCADIAN_REGULATION,36,Down,0.00514435095724103,0.183380446982005
24,WP_CHOLESTASIS,8,Up,0.00556798595662361,0.183380446982005
25,WP_CODEINE_AND_MORPHINE_METABOLISM,1,Up,0.00557726420261572,0.183380446982005
26,WP_SARSCOV2_AND_COVID19_PATHWAY,6,Up,0.00737415581047415,0.225427661916604
27,WP_RAS_AND_BRADYKININ_PATHWAYS_IN_COVID19,12,Down,0.00740455823813664,0.225427661916604
28,WP_PROXIMAL_TUBULE_TRANSPORT,25,Down,0.00796688883954222,0.227885048799965
29,WP_UDPDERIVED_SUGARS_SYNTHESIS_IN_FIBROBLASTS,10,Up,0.00846344988181882,0.227885048799965
30,WP_GLUCOCORTICOID_RECEPTOR_PATHWAY,48,Down,0.00874119271547148,0.227885048799965
31,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_4,10,Up,0.00954553419543574,0.227885048799965
32,WP_PROSTAGLANDIN_SIGNALING,21,Down,0.00955335677102828,0.227885048799965
33,WP_MRNA_PROTEIN_AND_METABOLITE_INDUCATION_PATHWAY_BY_CYCLOSPORIN_A,5,Down,0.0098277076502241,0.227885048799965
34,WP_ANGIOTENSIN_II_RECEPTOR_TYPE_1_PATHWAY,18,Up,0.00983096498547333,0.227885048799965
35,WP_SIGNAL_TRANSDUCTION_THROUGH_IL1R,27,Down,0.0102167145597583,0.227885048799965
36,WP_HUNGER_AND_SATIETY,2,Up,0.0102451170219013,0.227885048799965
37,WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION,18,Down,0.0102575995201931,0.227885048799965
38,WP_MIRNA_ROLE_IN_IMMUNE_RESPONSE_IN_SEPSIS,32,Down,0.0130611781830573,0.281743549490392
39,WP_2Q211_COPY_NUMBER_VARIATION_SYNDROME,8,Down,0.0133673946838507,0.281743549490392
40,WP_GLIAL_CELL_DIFFERENTIATION,4,Down,0.0140409187679827,0.288540880682044
41,WP_LIPID_PARTICLES_COMPOSITION,4,Up,0.0147795839966256,0.293670937098293
42,WP_FOXA2_PATHWAY,9,Up,0.0154181165920586,0.293670937098293
43,WP_AMINO_ACID_TRANSPORT_DEFECTS_IEMS,2,Down,0.0157732480618466,0.293670937098293
44,WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES,40,Up,0.0162490010518323,0.293670937098293
45,WP_SREBF_AND_MIR33_IN_CHOLESTEROL_AND_LIPID_HOMEOSTASIS,14,Up,0.0166098398401615,0.293670937098293
46,WP_NEUROINFLAMMATION,10,Down,0.0170458271432403,0.293670937098293
47,WP_PTDINS45P2_IN_CYTOKINESIS_PATHWAY,8,Down,0.0174152255497267,0.293670937098293
48,WP_DEVELOPMENT_AND_HETEROGENEITY_OF_THE_ILC_FAMILY,12,Down,0.0174577256489213,0.293670937098293
49,WP_IRON_METABOLISM_IN_PLACENTA,8,Up,0.0175059317734992,0.293670937098293
50,WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS,22,Up,0.019448733546506,0.313539831984987
51,WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES,46,Down,0.0196895588127383,0.313539831984987
52,WP_OPIOID_RECEPTOR_PATHWAYS,24,Down,0.0198346365732595,0.313539831984987
53,WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING,53,Down,0.0207309309150253,0.316736135076975
54,WP_17P133_YWHAE_COPY_NUMBER_VARIATION,18,Down,0.0208074833262246,0.316736135076975
55,WP_COMPLEMENT_SYSTEM,50,Up,0.0216624928864838,0.323755802776177
56,WP_DRUG_INDUCTION_OF_BILE_ACID_PATHWAY,3,Up,0.0233416479920836,0.339792165595474
57,WP_OSTEOBLAST_SIGNALING,3,Down,0.0237793131879181,0.339792165595474
58,WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS,11,Down,0.0250901559466636,0.339792165595474
59,WP_2Q112_COPY_NUMBER_VARIATION_SYNDROME,21,Down,0.0251353965500929,0.339792165595474
60,WP_PPARALPHA_PATHWAY,15,Up,0.0253019653162503,0.339792165595474
61,WP_HFE_EFFECT_ON_HEPCIDIN_PRODUCTION,3,Up,0.025821598791686,0.339792165595474
62,WP_KETOGENESIS_AND_KETOLYSIS,5,Up,0.0259638830733203,0.339792165595474
63,WP_SEROTONIN_TRANSPORTER_ACTIVITY,4,Down,0.0262009289719753,0.339792165595474
64,WP_CYTOKINECYTOKINE_RECEPTOR_INTERACTION,87,Up,0.0270741842104735,0.339792165595474
65,WP_RETINOBLASTOMA_GENE_IN_CANCER,65,Down,0.0272727012452078,0.339792165595474
66,WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION,7,Down,0.0272825826390527,0.339792165595474
67,WP_GNAQ_PATHWAYS_IN_PORTWINE_STAIN,19,Down,0.0281907839451931,0.345863050790279
68,WP_PERTURBATIONS_TO_HOSTCELL_AUTOPHAGY_INDUCED_BY_SARSCOV2_PROTEINS,40,Down,0.02868401843928,0.346739164074826
69,WP_POSTCOVID_NEUROINFLAMMATION,11,Down,0.0292973530209825,0.349020640336922
70,WP_PILOCYTIC_ASTROCYTOMA,6,Up,0.0298959617515071,0.351064007996269
71,WP_SELENIUM_METABOLISM_AND_SELENOPROTEINS,34,Down,0.0321467755124362,0.372178161566514
72,WP_ETHANOL_METABOLISM_PRODUCTION_OF_ROS_BY_CYP2E1,8,Down,0.0336621250686916,0.374971154754867
73,WP_ENTEROHEPATIC_CIRCULATION_OF_BILE_ACIDS,2,Up,0.0341334292924016,0.374971154754867
74,WP_PHYSIOLOGICAL_AND_PATHOLOGICAL_HYPERTROPHY_OF_THE_HEART,16,Down,0.0345149563388245,0.374971154754867
75,WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY,28,Down,0.0345855317253624,0.374971154754867
76,WP_ACQUIRED_PARTIAL_LIPODYSTROPHY_BARRAQUERSIMONS_SYNDROME,10,Up,0.0346688658897444,0.374971154754867
77,WP_TAR_SYNDROME,43,Down,0.0352759494576206,0.376582213690443
78,WP_PHOTODYNAMIC_THERAPYINDUCED_NFKB_SURVIVAL_SIGNALING,23,Down,0.038390023841576,0.400283073385497
79,WP_CORTICOTROPINRELEASING_HORMONE_SIGNALING,60,Down,0.0385585771185378,0.400283073385497
80,WP_HYPERTROPHY_MODEL,13,Down,0.0395265140895722,0.400283073385497
81,WP_TCA_CYCLE_AKA_KREBS_OR_CITRIC_ACID_CYCLE,18,Down,0.039573506787343,0.400283073385497
82,WP_PHASE_I_BIOTRANSFORMATIONS_NONP450,5,Up,0.040059116361108,0.400283073385497
83,WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION,20,Down,0.0404178772396548,0.400283073385497
84,WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY,13,Up,0.0409777643100731,0.400996693605716
85,WP_SELENIUM_MICRONUTRIENT_NETWORK,48,Down,0.0418463818825796,0.404679128323299
86,WP_BENZOAPYRENE_METABOLISM,5,Up,0.0428837701771013,0.407505895620488
87,WP_16P112_DISTAL_DELETION_SYNDROME,20,Up,0.0435690573797684,0.407505895620488
88,WP_BIOSYNTHESIS_AND_REGENERATION_OF_TETRAHYDROBIOPTERIN_AND_CATABOLISM_OF_PHENYLALANINE,6,Down,0.0440334370909193,0.407505895620488
89,WP_GASTRIN_SIGNALING,91,Down,0.0445366575440183,0.407505895620488
90,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873,23,Down,0.0446174338270607,0.407505895620488
91,WP_IMATINIB_AND_CHRONIC_MYELOID_LEUKEMIA,15,Up,0.0451528320185703,0.407864043068844
92,WP_PROTEASOME_DEGRADATION,57,Down,0.0463333410042578,0.412016853485364
93,WP_RALA_DOWNSTREAM_REGULATED_GENES,11,Down,0.0466150454673222,0.412016853485364
94,WP_EV_RELEASE_FROM_CARDIAC_CELLS_AND_THEIR_FUNCTIONAL_EFFECTS,3,Down,0.0479355884111512,0.419181422063471
95,WP_AGERAGE_PATHWAY,53,Down,0.0489301597059279,0.42337464503445
96,WP_DNA_REPLICATION,34,Down,0.0511024923447836,0.43756509070221
97,WP_EUKARYOTIC_TRANSCRIPTION_INITIATION,42,Down,0.0523536676753334,0.43946321654506
98,WP_ALTERNATIVE_PATHWAY_OF_FETAL_ANDROGEN_SYNTHESIS,3,Down,0.0523934248435716,0.43946321654506
99,WP_LTF_DANGER_SIGNAL_RESPONSE_PATHWAY,15,Down,0.0567052603563112,0.469749191567509
100,WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION,40,Down,0.0584362852822962,0.469749191567509
101,WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING,31,Down,0.0586275699965043,0.469749191567509
102,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_INTERFERON_INDUCTION,32,Down,0.0587999486221924,0.469749191567509
103,WP_H19_RBE2F1_AND_CDKBETACATENIN_IN_COLORECTAL_CANCER,9,Down,0.0591004495083922,0.469749191567509
104,WP_GLYCOSPHINGOLIPID_METABOLISM,13,Down,0.0594329877409014,0.469749191567509
105,WP_NOVEL_INTRACELLULAR_COMPONENTS_OF_RIGILIKE_RECEPTOR_PATHWAY,48,Down,0.0618227877647763,0.483984109929963
106,WP_SELECTIVE_EXPRESSION_OF_CHEMOKINE_RECEPTORS_DURING_TCELL_POLARIZATION,10,Up,0.0642684484630348,0.498383628647308
107,WP_FEMALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,10,Up,0.0650738292326205,0.499912968497328
108,WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY,29,Up,0.0660772030877168,0.500777884046119
109,WP_INDUCTION_OF_AUTOPHAGY_AND_TOLLLIKE_RECEPTOR_SIGNALING_BY_GRAPHENE_OXIDE,8,Down,0.0664048532372591,0.500777884046119
110,WP_MONOAMINE_TRANSPORT,11,Down,0.0674932538810601,0.504358679002104
111,WP_REGUCALCIN_IN_PROXIMAL_TUBULE_EPITHELIAL_KIDNEY_CELLS,24,Up,0.0704721189235324,0.521874610406699
112,WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER,24,Down,0.0718524770008474,0.522214173233842
113,WP_NRXN1_DELETION_SYNDROME,2,Up,0.0738204756716925,0.522214173233842
114,WP_IL1_SIGNALING,52,Down,0.0738523547234391,0.522214173233842
115,WP_HIPPOYAP_SIGNALING,16,Down,0.0751484563861316,0.522214173233842
116,WP_CYTOSOLIC_DNASENSING_PATHWAY,53,Down,0.0751913751368442,0.522214173233842
117,WP_OSTEOCLAST_SIGNALING,9,Down,0.0752451056392815,0.522214173233842
118,WP_PYRIMIDINE_METABOLISM,71,Down,0.075517657048512,0.522214173233842
119,WP_OMEGA9_FATTY_ACID_SYNTHESIS,9,Up,0.0756003486798385,0.522214173233842
120,WP_G1_TO_S_CELL_CYCLE_CONTROL,50,Down,0.0763181388325871,0.522779251003221
121,WP_COVID19_AND_ENDOTHELIAL_CELL_SENESCENCE,4,Down,0.0782439761354401,0.531541722176296
122,WP_VITAMIN_B6DEPENDENT_AND_RESPONSIVE_DISORDERS,5,Down,0.0827158004907937,0.55731465576584
123,WP_EFFECT_OF_PROGERIN_ON_GENES_INVOLVED_IN_PROGERIA,19,Up,0.0858412765918139,0.573670970394073
124,WP_LIVER_X_RECEPTOR_PATHWAY,5,Up,0.0867438619954794,0.575027859357129
125,WP_PI3KAKTMTOR_VITAMIN_D3_SIGNALING,18,Up,0.0907731179970478,0.596924023948586
126,WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY,46,Down,0.0924460860525819,0.603100656628749
127,WP_LINOLEIC_ACID_METABOLISM_AFFECTED_BY_SARSCOV2,3,Up,0.0935599291205234,0.605561116039923
128,WP_KALLMANN_SYNDROME,10,Up,0.094608390230361,0.607563256010599
129,WP_FGFR3_SIGNALING_IN_CHONDROCYTE_PROLIFERATION_AND_TERMINAL_DIFFERENTIATION,14,Down,0.0996708578694168,0.630520459806689
130,WP_GLYCOSAMINOGLYCAN_DEGRADATION,14,Down,0.0997173476579922,0.630520459806689
131,WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY,44,Down,0.102312556127476,0.641991764402938
132,WP_NONALCOHOLIC_FATTY_LIVER_DISEASE,129,Down,0.106938254471023,0.662671136864354
133,WP_MITOCHONDRIAL_BETAOXIDATION,8,Down,0.107220512412359,0.662671136864354
134,WP_INVOLVEMENT_OF_SECRETASE_IN_NEURODEGENERATIVE_DISEASES,13,Up,0.108336165470391,0.664569612064636
135,WP_NAD_METABOLISM_IN_ONCOGENEINDUCED_SENESCENCE_AND_MITOCHONDRIAL_DYSFUNCTIONASSOCIATED_SENESCENCE,18,Down,0.112543850356468,0.682582700586174
136,WP_UREA_CYCLE_AND_ASSOCIATED_PATHWAYS,12,Down,0.112933390851241,0.682582700586174
137,WP_HYPOTHETICAL_CRANIOFACIAL_DEVELOPMENT_PATHWAY,2,Down,0.114157647173179,0.682596556639806
138,WP_APOE_AND_MIR146_IN_INFLAMMATION_AND_ATHEROSCLEROSIS,8,Up,0.115161231287513,0.682596556639806
139,WP_MAP3K1_ROLE_IN_PROMOTING_AND_BLOCKING_GONADAL_DETERMINATION,10,Down,0.115426911645904,0.682596556639806
140,WP_ACUTE_MYELOID_LEUKEMIA,54,Up,0.116692128517094,0.685149497436082
141,WP_HISTONE_MODIFICATIONS,35,Up,0.11859014413315,0.68554153687577
142,WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT,22,Down,0.119016901927909,0.68554153687577
143,WP_MULTIPLE_EPIPHYSEAL_DYSPLASIA_AND_PSEUDOACHONDROPLASIA_GENES,1,Up,0.119260875636539,0.68554153687577
144,WP_PROSURVIVAL_SIGNALING_OF_NEUROPROTECTIN_D1,15,Down,0.12513044169835,0.698398787300409
145,WP_WHITE_FAT_CELL_DIFFERENTIATION,22,Up,0.125426623564492,0.698398787300409
146,WP_PHOTODYNAMIC_THERAPYINDUCED_UNFOLDED_PROTEIN_RESPONSE,22,Down,0.126290139073781,0.698398787300409
147,WP_ALTERED_GLYCOSYLATION_OF_MUC1_IN_TUMOR_MICROENVIRONMENT,7,Down,0.128025960795281,0.698398787300409
148,WP_NAD_METABOLISM_SIRTUINS_AND_AGING,10,Up,0.128392733409443,0.698398787300409
149,WP_DEREGULATION_OF_RAB_AND_RAB_EFFECTOR_GENES_IN_BLADDER_CANCER,10,Up,0.128543248479814,0.698398787300409
150,WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY,54,Down,0.128677578866148,0.698398787300409
151,WP_METABOLIC_PATHWAY_OF_LDL_HDL_AND_TG_INCLUDING_DISEASES,8,Up,0.12885420230975,0.698398787300409
152,WP_SULFATASE_AND_AROMATASE_PATHWAY,2,Up,0.129167634649353,0.698398787300409
153,WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA,9,Up,0.130396070004525,0.698398787300409
154,WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS,37,Up,0.130869306262848,0.698398787300409
155,WP_SEBALEIC_ACID_FORMATION_AND_METABOLISM,3,Up,0.132388227176789,0.698398787300409
156,WP_PDGF_PATHWAY,36,Down,0.132542835546063,0.698398787300409
157,WP_CILIARY_LANDSCAPE,182,Down,0.134161010916606,0.699661561733995
158,WP_NANOMATERIAL_INDUCED_APOPTOSIS,18,Down,0.134527110891463,0.699661561733995
159,WP_WNT_SIGNALING_IN_KIDNEY_DISEASE,12,Down,0.135335995517889,0.699661561733995
160,WP_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS,30,Down,0.13745754828688,0.70259162611383
161,WP_DUAL_HIJACK_MODEL_OF_VIF_IN_HIV_INFECTION,8,Down,0.13784113815292,0.70259162611383
162,WP_SYNAPTIC_VESICLE_PATHWAY,21,Down,0.13947466359849,0.70259162611383
163,WP_HIJACK_OF_UBIQUITINATION_BY_SARSCOV2,8,Down,0.141375130840734,0.70259162611383
164,WP_MEASLES_VIRUS_INFECTION,100,Down,0.141712197664542,0.70259162611383
165,WP_DISORDERS_OF_GALACTOSE_METABOLISM,9,Up,0.141974289106661,0.70259162611383
166,WP_INFLUENCE_OF_LAMINOPATHIES_ON_WNT_SIGNALING,27,Up,0.142055476527731,0.70259162611383
167,WP_REGULATION_OF_SISTER_CHROMATID_SEPARATION_AT_THE_METAPHASEANAPHASE_TRANSITION,11,Down,0.143266975068707,0.70259162611383
168,WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS,8,Up,0.143595368840783,0.70259162611383
169,WP_SILDENAFIL_TREATMENT,11,Up,0.144739936498924,0.70400134794151
170,WP_MITOCHONDRIAL_COMPLEX_I_ASSEMBLY_MODEL_OXPHOS_SYSTEM,50,Down,0.147176953193179,0.707909572924731
171,WP_THERMOGENESIS,72,Up,0.147275069692602,0.707909572924731
172,WP_IMMUNE_INFILTRATION_IN_PANCREATIC_CANCER,13,Down,0.14812706392099,0.707909572924731
173,WP_EBSTEINBARR_VIRUS_LMP1_SIGNALING,21,Down,0.150671756721638,0.712423249498248
174,WP_RIBOFLAVIN_AND_COQ_DISORDERS,13,Down,0.15087002780988,0.712423249498248
175,WP_MINERALOCORTICOID_BIOSYNTHESIS,5,Up,0.15182634191768,0.712423249498248
176,WP_METABOLIC_REPROGRAMMING_IN_COLON_CANCER,38,Down,0.153359756126954,0.712423249498248
177,WP_METHIONINE_DE_NOVO_AND_SALVAGE_PATHWAY,18,Down,0.15340500627882,0.712423249498248
178,WP_OCTADECANOID_FORMATION_FROM_LINOLEIC_ACID,2,Up,0.156768168183946,0.712834614679755
179,WP_COMPLEMENT_AND_COAGULATION_CASCADES,23,Up,0.156899162326988,0.712834614679755
180,WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES,23,Up,0.156899162326988,0.712834614679755
181,WP_INTRAFLAGELLAR_TRANSPORT_PROTEINS_BINDING_TO_DYNEIN,21,Down,0.156962366492744,0.712834614679755
182,WP_LIPID_METABOLISM_IN_SENESCENT_CELLS,10,Down,0.158911534543613,0.715464795074804
183,WP_MITOCHONDRIAL_COMPLEX_IV_ASSEMBLY,31,Down,0.159282308392566,0.715464795074804
184,WP_IRON_METABOLISM_DISORDERS,10,Up,0.160817889398193,0.718436440681058
185,WP_VASOPRESSINREGULATED_WATER_REABSORPTION,34,Down,0.162142337348047,0.720437844865374
186,WP_ANTIVIRAL_AND_ANTIINFLAMMATORY_EFFECTS_OF_NRF2_ON_SARSCOV2_PATHWAY,19,Down,0.163973423614042,0.724656743068508
187,WP_VITAMIN_D_IN_INFLAMMATORY_DISEASES,20,Down,0.166282447359859,0.730931399624621
188,WP_GENES_CONTROLLING_NEPHROGENESIS,13,Down,0.168721630921572,0.732066736478871
189,WP_CELL_CYCLE,92,Down,0.169328142499917,0.732066736478871
190,WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER,73,Down,0.16942133792391,0.732066736478871
191,WP_DRAVET_SYNDROME,11,Down,0.170103098135601,0.732066736478871
192,WP_2Q13_COPY_NUMBER_VARIATION_SYNDROME,37,Down,0.174537952357486,0.747240608530487
193,WP_SEROTONIN_AND_ANXIETYRELATED_EVENTS,4,Up,0.177065085175644,0.753701958999791
194,WP_INCLUSION_BODY_MYOSITIS,9,Up,0.177880997622822,0.753701958999791
195,WP_ULCERATIVE_COLITIS_SIGNALING,12,Up,0.183778879099052,0.774582296086443
196,WP_LDL_INFLUENCE_ON_CD14_AND_TLR4,17,Down,0.184960650919237,0.774582296086443
197,WP_LEUKOCYTEINTRINSIC_HIPPO_PATHWAY_FUNCTIONS,23,Down,0.185635903076678,0.774582296086443
198,WP_GLYCOSYLATION_AND_RELATED_CONGENITAL_DEFECTS,24,Down,0.189244642889598,0.783436099630167
199,WP_PPAR_SIGNALING,36,Up,0.190285536220782,0.783436099630167
200,WP_TLR4_SIGNALING_AND_TOLERANCE,26,Down,0.190658959574141,0.783436099630167
201,WP_ECTODERM_DIFFERENTIATION,75,Up,0.191834971746686,0.783436099630167
202,WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,71,Down,0.193320397760328,0.783436099630167
203,WP_ALSTROM_SYNDROME,27,Down,0.193476311709153,0.783436099630167
204,WP_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE,58,Down,0.194711846789361,0.784574206180659
205,WP_PATHWAYS_OF_NUCLEIC_ACID_METABOLISM_AND_INNATE_IMMUNE_SENSING,11,Down,0.196847149539399,0.789309058153102
206,WP_LACTO_SERIES_SPHINGOLIPID_METABOLISM,1,Down,0.201014731509165,0.802107326701619
207,WP_ZINC_HOMEOSTASIS,23,Up,0.203782390041045,0.805877568896386
208,WP_ROBO4_AND_VEGF_SIGNALING_CROSSTALK,3,Down,0.203920358066239,0.805877568896386
209,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,72,Up,0.204985577689479,0.806211219429434
210,WP_GABA_RECEPTOR_SIGNALING,9,Down,0.206646121573872,0.807325178641026
211,WP_FATTY_ACID_OMEGAOXIDATION,2,Down,0.207233105466249,0.807325178641026
212,WP_ATR_SIGNALING,10,Down,0.210086351556291,0.814580098958825
213,WP_AUTOPHAGY_IN_PANCREATIC_DUCTAL_ADENOCARCINOMA,19,Down,0.213604986523634,0.824334736725012
214,WP_GALANIN_RECEPTOR_PATHWAY,11,Down,0.2151474203485,0.826407380964798
215,WP_CCL18_SIGNALING,20,Up,0.216171077406799,0.826477328504134
216,WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA,51,Up,0.218362353347653,0.830990066906346
217,WP_LEPTININSULIN_SIGNALING_OVERLAP,13,Down,0.220129045396269,0.831228523537224
218,WP_RETINOL_METABOLISM,6,Down,0.220885051330057,0.831228523537224
219,WP_COVID19_STRUCTURAL_COVERAGE_MAP,19,Up,0.221458694227071,0.831228523537224
220,WP_1P36_COPY_NUMBER_VARIATION_SYNDROME,67,Down,0.225077887459525,0.836559388102638
221,WP_GDNFRET_SIGNALING_AXIS,4,Down,0.225242210588944,0.836559388102638
222,WP_MICROTUBULE_CYTOSKELETON_REGULATION,34,Down,0.230816119702931,0.836559388102638
223,WP_SARSCOV2_MITOCHONDRIAL_CHRONIC_OXIDATIVE_STRESS_AND_ENDOTHELIAL_DYSFUNCTION,20,Down,0.231566764310453,0.836559388102638
224,WP_EICOSANOID_SYNTHESIS,13,Up,0.231949354989552,0.836559388102638
225,WP_OXIDATION_BY_CYTOCHROME_P450,14,Down,0.232060945212711,0.836559388102638
226,WP_BIOTIN_METABOLISM_INCLUDING_IMDS,9,Up,0.232680010431504,0.836559388102638
227,WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICRORNAS_IN_TUMOR_MICROENVIRONMENT,21,Up,0.234845616460356,0.836559388102638
228,WP_GLUCURONIDATION,7,Up,0.235518718626925,0.836559388102638
229,WP_DISORDERS_OF_BILE_ACID_SYNTHESIS_AND_BILIARY_TRANSPORT,10,Up,0.236484744338878,0.836559388102638
230,WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY,38,Up,0.236962751108567,0.836559388102638
231,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING,31,Down,0.237045061388705,0.836559388102638
232,WP_TYPE_I_COLLAGEN_SYNTHESIS_IN_THE_CONTEXT_OF_OSTEOGENESIS_IMPERFECTA,17,Up,0.239536645496647,0.836559388102638
233,WP_EBOLA_VIRUS_INFECTION_IN_HOST,105,Down,0.240171265432834,0.836559388102638
234,WP_TYPE_I_INTERFERON_INDUCTION_AND_SIGNALING_DURING_SARSCOV2_INFECTION,25,Down,0.241043232729606,0.836559388102638
235,WP_G13_SIGNALING,29,Down,0.241705730176089,0.836559388102638
236,WP_IDO_METABOLIC_PATHWAY,6,Down,0.242162519602501,0.836559388102638
237,WP_5Q35_COPY_NUMBER_VARIATION,76,Up,0.242383816948962,0.836559388102638
238,WP_NANOMATERIALINDUCED_INFLAMMASOME_ACTIVATION,6,Down,0.24307601432899,0.836559388102638
239,WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION,19,Up,0.24324388072651,0.836559388102638
240,WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II,52,Up,0.244250916234347,0.836559388102638
241,WP_LIPID_METABOLISM_PATHWAY,23,Up,0.246988013042119,0.840422342164967
242,WP_SEROTONIN_RECEPTOR_467_AND_NR3C_SIGNALING,16,Down,0.247423609250513,0.840422342164967
243,WP_NAD_BIOSYNTHETIC_PATHWAYS,18,Down,0.249457254698207,0.843843059102578
244,WP_CLASSICAL_PATHWAY_OF_STEROIDOGENESIS_WITH_GLUCOCORTICOID_AND_MINERALOCORTICOID_METABOLISM,4,Down,0.250798552278477,0.844903319561098
245,WP_UNFOLDED_PROTEIN_RESPONSE,24,Down,0.25220794165346,0.845089928116383
246,WP_AUTOSOMAL_RECESSIVE_OSTEOPETROSIS_PATHWAYS,9,Down,0.252910124472786,0.845089928116383
247,WP_HORMONAL_CONTROL_OF_PUBERTAL_GROWTH_SPURT,1,Up,0.258246546108038,0.857909320667573
248,WP_VITAMIN_D_RECEPTOR_PATHWAY,81,Up,0.2588339556272,0.857909320667573
249,WP_NGLYCAN_BIOSYNTHESIS,52,Down,0.2608790007863,0.861215014643929
250,WP_ENDODERM_DIFFERENTIATION,80,Up,0.262290150521723,0.862410014915426
251,WP_ERK_PATHWAY_IN_HUNTINGTONS_DISEASE,12,Down,0.264088808089336,0.86486454282643
252,WP_SMALL_CELL_LUNG_CANCER,68,Down,0.266492452442929,0.867770905522638
253,WP_APOPTOSIS,71,Down,0.267087638804413,0.867770905522638
254,WP_DNA_DAMAGE_RESPONSE,57,Down,0.273697633505779,0.873529781705868
255,WP_PURINE_METABOLISM_AND_RELATED_DISORDERS,18,Down,0.275160852478694,0.873529781705868
256,WP_TARGET_OF_RAPAMYCIN_SIGNALING,31,Down,0.275564066945964,0.873529781705868
257,WP_GENES_TARGETED_BY_MIRNAS_IN_ADIPOCYTES,8,Up,0.276373318301981,0.873529781705868
258,WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,47,Down,0.277275474315227,0.873529781705868
259,WP_APOPTOSIS_MODULATION_AND_SIGNALING,76,Down,0.278397838175941,0.873529781705868
260,WP_PI3KAKTMTOR_SIGNALING_AND_THERAPEUTIC_OPPORTUNITIES_IN_PROSTATE_CANCER,30,Down,0.278455568488589,0.873529781705868
261,WP_KREBS_CYCLE_DISORDERS,11,Down,0.279022640827898,0.873529781705868
262,WP_TRANSCRIPTION_FACTORS_REGULATE_MIRNAS_RELATED_TO_CARDIAC_HYPERTROPHY,6,Up,0.279941539812936,0.873529781705868
263,WP_SARSCOV2_ALTERING_ANGIOGENESIS_VIA_NRP1,3,Up,0.280658102157502,0.873529781705868
264,WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION,19,Up,0.281772462908237,0.873529781705868
265,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586,36,Down,0.283279451328747,0.873529781705868
266,WP_NOTCH_SIGNALING_WP268,34,Down,0.283659534560497,0.873529781705868
267,WP_13Q1212_COPY_NUMBER_VARIATION,20,Down,0.284572110911139,0.873529781705868
268,WP_8Q1123_RB1CC1_COPY_NUMBER_VARIATION,16,Down,0.285610785022724,0.873529781705868
269,WP_APOPTOSIS_MODULATION_BY_HSP70,17,Down,0.285863152407395,0.873529781705868
270,WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING,104,Down,0.287649139249281,0.8757318239367
271,WP_NUCLEAR_RECEPTORS_METAPATHWAY,173,Down,0.291648799203637,0.884632151089997
272,WP_SEROTONIN_RECEPTOR_2_AND_ELKSRFGATA4_SIGNALING,15,Down,0.296008631905697,0.888816787755301
273,WP_3Q29_COPY_NUMBER_VARIATION_SYNDROME,51,Down,0.297364261781366,0.888816787755301
274,WP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_HEAT_SHOCK_PROTEINS,40,Down,0.298037280005582,0.888816787755301
275,WP_CONGENITAL_GENERALIZED_LIPODYSTROPHY,13,Up,0.300174182043588,0.888816787755301
276,WP_GLUCOSE_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,7,Up,0.300696473620768,0.888816787755301
277,WP_GLYCOSAMINOGLYCAN_SYNTHESIS_IN_FIBROBLASTS,24,Up,0.300754148484038,0.888816787755301
278,WP_PGK1_PKM2_KHKCKHKA_ACTING_AS_PROTEIN_KINASES,11,Down,0.30163681292264,0.888816787755301
279,WP_PROTEOGLYCAN_BIOSYNTHESIS,14,Up,0.301678690734464,0.888816787755301
280,WP_MESODERMAL_COMMITMENT_PATHWAY,72,Up,0.305320008394719,0.891824291373973
281,WP_KLEEFSTRA_SYNDROME,25,Up,0.306235649933338,0.891824291373973
282,WP_BMP_SIGNALING_IN_EYELID_DEVELOPMENT,8,Down,0.306894472719789,0.891824291373973
283,WP_IL26_SIGNALING,31,Down,0.307994486657644,0.891824291373973
284,WP_OXIDATIVE_PHOSPHORYLATION,50,Down,0.308124207725314,0.891824291373973
285,WP_LUNG_PATHOLOGY_OF_COVID19,14,Down,0.313021117787556,0.902818802882003
286,WP_ENERGY_METABOLISM,41,Up,0.315242015112336,0.903867832999023
287,WP_MITOCHONDRIAL_GENE_EXPRESSION,16,Up,0.317053962038242,0.903867832999023
288,WP_OXIDATIVE_DAMAGE_RESPONSE,33,Down,0.317206185715747,0.903867832999023
289,WP_STEROID_HORMONE_PRECURSOR_BIOSYNTHESIS,2,Up,0.31886254349978,0.903867832999023
290,WP_PROLACTIN_SIGNALING,69,Down,0.318882812128609,0.903867832999023
291,WP_BENZENE_METABOLISM,3,Up,0.323053103357363,0.908373411260171
292,WP_INTERACTOME_OF_POLYCOMB_REPRESSIVE_COMPLEX_2_PRC2,16,Down,0.323259860475705,0.908373411260171
293,WP_DOPAMINERGIC_NEUROGENESIS,5,Down,0.324459225102303,0.908373411260171
294,WP_COPPER_HOMEOSTASIS,40,Up,0.327054279192972,0.908373411260171
295,WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY,31,Down,0.327066505935283,0.908373411260171
296,WP_METABOLISM_OF_SPHINGOLIPIDS_IN_ER_AND_GOLGI_APPARATUS,12,Down,0.327102834225074,0.908373411260171
297,WP_GLYCOLYSIS_AND_GLUCONEOGENESIS,28,Down,0.330040558457999,0.91344558603527
298,WP_GLUCOCORTICOID_BIOSYNTHESIS,6,Up,0.334873509917655,0.923093023042829
299,WP_HEPATITIS_B_INFECTION,115,Down,0.335879825884801,0.923093023042829
300,WP_THIAMINE_METABOLIC_PATHWAYS,9,Up,0.338819563459826,0.923093023042829
301,WP_THYROXINE_THYROID_HORMONE_PRODUCTION,15,Down,0.338861381459836,0.923093023042829
302,WP_LEPTIN_AND_ADIPONECTIN,8,Down,0.340837487378457,0.923093023042829
303,WP_CATABOLISM_OF_SKELETAL_MUSCLE_IN_CACHEXIA,35,Up,0.341312288109041,0.923093023042829
304,WP_NICOTINE_EFFECT_ON_DOPAMINERGIC_NEURONS,5,Up,0.341654170209394,0.923093023042829
305,WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS,52,Down,0.342574756172002,0.923093023042829
306,WP_GABA_METABOLISM_AKA_GHB,4,Up,0.343633169161929,0.923093023042829
307,WP_FOLATEALCOHOL_AND_CANCER_PATHWAY_HYPOTHESES,6,Down,0.348729362633953,0.929281814616224
308,WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION,11,Up,0.34875097661891,0.929281814616224
309,WP_NRF2_PATHWAY,68,Down,0.349328565348434,0.929281814616224
310,WP_FGF23_SIGNALING_IN_HYPOPHOSPHATEMIC_RICKETS_AND_RELATED_DISORDERS,7,Up,0.352756770976127,0.933433729890568
311,WP_INTEGRATED_CANCER_PATHWAY,39,Up,0.353960149111365,0.933433729890568
312,WP_ACTIVATION_OF_NLRP3_INFLAMMASOME_BY_SARSCOV2,7,Down,0.354296014265033,0.933433729890568
313,WP_ID_SIGNALING,11,Up,0.355655598053614,0.934022049840482
314,WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING,5,Down,0.356952616303635,0.934442836310789
315,WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME,80,Down,0.360636154314984,0.941088631260053
316,WP_NUCLEAR_RECEPTORS,20,Up,0.363886422492791,0.94656531420593
317,WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME,43,Up,0.367072015379207,0.948581493282562
318,WP_GENES_ASSOCIATED_WITH_THE_DEVELOPMENT_OF_RHEUMATOID_ARTHRITIS,10,Up,0.367770414974751,0.948581493282562
319,WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY,2,Up,0.368123474887028,0.948581493282562
320,WP_BREAST_CANCER_PATHWAY,82,Down,0.370475088759252,0.949784713420534
321,WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR,21,Down,0.37090132969342,0.949784713420534
322,WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA,48,Down,0.372289352568309,0.950378409351399
323,WP_INTRACELLULAR_TRAFFICKING_PROTEINS_INVOLVED_IN_CMT_NEUROPATHY,20,Down,0.374979671593689,0.951324882850571
324,WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER,60,Down,0.380084909740299,0.951324882850571
325,WP_ROLES_OF_CERAMIDES_IN_DEVELOPMENT_OF_INSULIN_RESISTANCE,15,Down,0.381747183822119,0.951324882850571
326,WP_GENE_REGULATORY_NETWORK_MODELING_SOMITOGENESIS,3,Down,0.382449925299506,0.951324882850571
327,WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX,18,Up,0.385908631456431,0.951324882850571
328,WP_CELLS_AND_MOLECULES_INVOLVED_IN_LOCAL_ACUTE_INFLAMMATORY_RESPONSE,11,Down,0.386079411209077,0.951324882850571
329,WP_LDLRAD4_AND_WHAT_WE_KNOW_ABOUT_IT,7,Up,0.386387882934777,0.951324882850571
330,WP_CONTROL_OF_IMMUNE_TOLERANCE_BY_VASOACTIVE_INTESTINAL_PEPTIDE,4,Up,0.387570204506358,0.951324882850571
331,WP_MIRNA_BIOGENESIS,6,Down,0.38803946492151,0.951324882850571
332,WP_NIPBL_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,7,Up,0.388255566940326,0.951324882850571
333,WP_ACETAMINOPHEN_IN_ANALGESIA_AND_ANTIPYRESIS,2,Up,0.388898533690129,0.951324882850571
334,WP_S1P_RECEPTOR_SIGNAL_TRANSDUCTION,17,Down,0.392322421252253,0.951324882850571
335,WP_15Q112_COPY_NUMBER_VARIATION_SYNDROME,9,Down,0.392463416318205,0.951324882850571
336,WP_ALZHEIMERS_DISEASE,181,Down,0.393981738888818,0.951324882850571
337,WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,181,Down,0.393981738888818,0.951324882850571
338,WP_CIRCADIAN_RHYTHM_GENES,114,Down,0.394938046524391,0.951324882850571
339,WP_NITRIC_OXIDE_METABOLISM_IN_CYSTIC_FIBROSIS,8,Up,0.39807458458363,0.951324882850571
340,WP_T_CELL_RECEPTOR_AND_COSTIMULATORY_SIGNALING,17,Down,0.399021274104342,0.951324882850571
341,WP_ONCOSTATIN_M_SIGNALING,52,Down,0.399921201486035,0.951324882850571
342,WP_METHYLATION_PATHWAYS,5,Up,0.400710400745486,0.951324882850571
343,WP_CELL_INTERACTIONS_OF_THE_PANCREATIC_CANCER_MICROENVIRONMENT,17,Up,0.401542565470113,0.951324882850571
344,WP_MAMMARY_GLAND_DEVELOPMENT_PREGNANCY_AND_LACTATION_STAGE_3_OF_4,15,Up,0.401794300981204,0.951324882850571
345,WP_HOMOLOGOUS_RECOMBINATION,11,Down,0.402887710025648,0.951324882850571
346,WP_OREXIN_RECEPTOR_PATHWAY,114,Down,0.404399985746977,0.951324882850571
347,WP_MAMMARY_GLAND_DEVELOPMENT_INVOLUTION_STAGE_4_OF_4,7,Up,0.407354154766159,0.951324882850571
348,WP_DIFFERENTIATION_OF_WHITE_AND_BROWN_ADIPOCYTE,9,Up,0.407661435148293,0.951324882850571
349,WP_PHOTODYNAMIC_THERAPYINDUCED_HIF1_SURVIVAL_SIGNALING,27,Down,0.408644380167829,0.951324882850571
350,WP_PARKINSONS_DISEASE_PATHWAY,25,Down,0.412503501696427,0.951324882850571
351,WP_IRINOTECAN_PATHWAY,5,Up,0.415960341112872,0.951324882850571
352,WP_G_PROTEIN_SIGNALING,59,Up,0.416776357858936,0.951324882850571
353,WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS,5,Up,0.416782511843795,0.951324882850571
354,WP_INTERFERONMEDIATED_SIGNALING,15,Up,0.417271574281752,0.951324882850571
355,WP_SERINE_METABOLISM,5,Down,0.418560096248189,0.951324882850571
356,WP_CAMKK2_PATHWAY,29,Up,0.420304561152674,0.951324882850571
357,WP_PHOTODYNAMIC_THERAPYINDUCED_NFE2L2_NRF2_SURVIVAL_SIGNALING,19,Up,0.421201369048874,0.951324882850571
358,WP_DISORDERS_OF_FRUCTOSE_METABOLISM,10,Down,0.421944429630782,0.951324882850571
359,WP_DYRK1A_INVOLVEMENT_REGARDING_CELL_PROLIFERATION_IN_BRAIN_DEVELOPMENT,47,Down,0.421954411987903,0.951324882850571
360,WP_NEOLACTO_SERIES_SPHINGOLIPID_METABOLISM,7,Down,0.422560656477024,0.951324882850571
361,WP_IL17_SIGNALING,25,Up,0.425455394564174,0.951324882850571
362,WP_TYPE_II_INTERFERON_SIGNALING,30,Down,0.42609070635709,0.951324882850571
363,WP_DEVELOPMENT_OF_PULMONARY_DENDRITIC_CELLS_AND_MACROPHAGE_SUBSETS,10,Up,0.426110353062651,0.951324882850571
364,WP_PEROXIREDOXIN_2_INDUCED_OVARIAN_FAILURE,4,Down,0.427689929333248,0.951324882850571
365,WP_CARDIAC_PROGENITOR_DIFFERENTIATION,12,Down,0.430274964741868,0.951324882850571
366,WP_RIOK1_AND_RIOK2_IN_EGFR_AND_PI3KMEDIATED_TUMORIGENESIS,14,Up,0.430870521771372,0.951324882850571
367,WP_BIOMARKERS_FOR_PYRIMIDINE_METABOLISM_DISORDERS,11,Down,0.432480578333091,0.951324882850571
368,WP_GENETIC_CAUSES_OF_PORTOSINUSOIDAL_VASCULAR_DISEASE,27,Down,0.433624958777519,0.951324882850571
369,WP_PREIMPLANTATION_EMBRYO,21,Up,0.43612031431435,0.951324882850571
370,WP_GROWTH_FACTORS_AND_HORMONES_IN_BETA_CELL_PROLIFERATION,19,Up,0.436342402803911,0.951324882850571
371,WP_PHOTODYNAMIC_THERAPYINDUCED_AP1_SURVIVAL_SIGNALING,38,Down,0.437271070878259,0.951324882850571
372,WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,75,Down,0.437623905557082,0.951324882850571
373,WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION,13,Up,0.438689579221436,0.951324882850571
374,WP_GASTRIC_CANCER_NETWORK_1,15,Down,0.438907913175191,0.951324882850571
375,WP_NUCLEOTIDE_EXCISION_REPAIR_IN_XERODERMA_PIGMENTOSUM,57,Down,0.439528215471773,0.951324882850571
376,WP_BMP2WNT4FOXO1_PATHWAY_IN_PRIMARY_ENDOMETRIAL_STROMAL_CELL_DIFFERENTIATION,5,Up,0.440406230707023,0.951324882850571
377,WP_MITOCHONDRIAL_COMPLEX_III_ASSEMBLY,15,Down,0.443940337133688,0.951324882850571
378,WP_METABOLIC_PATHWAYS_OF_FIBROBLASTS,19,Down,0.449175022958559,0.951324882850571
379,WP_DISORDERS_IN_KETOLYSIS,3,Up,0.449532428351066,0.951324882850571
380,WP_METASTATIC_BRAIN_TUMOR,6,Down,0.450958431368049,0.951324882850571
381,WP_INSULIN_SIGNALING,125,Down,0.451367045365947,0.951324882850571
382,WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,62,Up,0.451657271502462,0.951324882850571
383,WP_INTEGRINMEDIATED_CELL_ADHESION,69,Down,0.451696397204135,0.951324882850571
384,WP_6Q16_COPY_NUMBER_VARIATION,5,Up,0.453964307291681,0.951324882850571
385,WP_TRANSCRIPTIONAL_ACTIVATION_BY_NRF2_IN_RESPONSE_TO_PHYTOCHEMICALS,12,Up,0.455264391373069,0.951324882850571
386,WP_MTHFR_DEFICIENCY,18,Up,0.45603502542331,0.951324882850571
387,WP_STING_PATHWAY_IN_KAWASAKILIKE_DISEASE_AND_COVID19,18,Up,0.457208848975232,0.951324882850571
388,WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING,14,Down,0.458357072197261,0.951324882850571
389,WP_NAD_BIOSYNTHESIS_II_FROM_TRYPTOPHAN,7,Up,0.460180204574848,0.951324882850571
390,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,14,Up,0.460470982624092,0.951324882850571
391,WP_HEDGEHOG_SIGNALING_WP47,6,Down,0.461538320363529,0.951324882850571
392,WP_ELECTRON_TRANSPORT_CHAIN_OXPHOS_SYSTEM_IN_MITOCHONDRIA,86,Down,0.46204684945574,0.951324882850571
393,WP_GLYCEROPHOSPHOLIPID_BIOSYNTHETIC_PATHWAY,28,Down,0.462646102024538,0.951324882850571
394,WP_EFFECT_OF_INTESTINAL_MICROBIOME_ON_ANTICOAGULANT_RESPONSE_OF_VITAMIN_K_ANTAGONISTS,5,Up,0.463344876330753,0.951324882850571
395,WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS,34,Up,0.46378695545015,0.951324882850571
396,WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS,45,Down,0.46640847496607,0.951324882850571
397,WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME,46,Down,0.46933775956712,0.951324882850571
398,WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING,38,Down,0.469775520425344,0.951324882850571
399,WP_UROTENSINIIMEDIATED_SIGNALING,48,Up,0.46992290654321,0.951324882850571
400,WP_CANCER_IMMUNOTHERAPY_BY_CTLA4_BLOCKADE,12,Down,0.470424549704227,0.951324882850571
401,WP_AUTOPHAGY,27,Down,0.47165207045638,0.951324882850571
402,WP_INTERLEUKIN1_INDUCED_ACTIVATION_OF_NFKB,9,Down,0.471970032302662,0.951324882850571
403,WP_TOLLLIKE_RECEPTOR_SIGNALING_RELATED_TO_MYD88,29,Up,0.473705664569663,0.951324882850571
404,WP_EFFECT_OF_OMEGA3_PUFA_ON_HUNTINGTONS_DISEASE_PATHWAYS,79,Down,0.474260174839377,0.951324882850571
405,WP_TRANSCRIPTION_COFACTORS_SKI_AND_SKIL_PROTEIN_PARTNERS,13,Up,0.477840714371357,0.951324882850571
406,WP_ESTROGEN_METABOLISM_WP5276,8,Up,0.477915103571141,0.951324882850571
407,WP_BARDETBIEDL_SYNDROME,64,Up,0.478148720957661,0.951324882850571
408,WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING,40,Down,0.479956844286051,0.951324882850571
409,WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY,60,Down,0.4805244726483,0.951324882850571
410,WP_SULFATION_BIOTRANSFORMATION_REACTION,6,Down,0.480999486129088,0.951324882850571
411,WP_FTO_OBESITY_VARIANT_MECHANISM,2,Up,0.481781156657018,0.951324882850571
412,WP_MACROPHAGESTIMULATING_PROTEIN_MSP_SIGNALING,72,Down,0.482136004401859,0.951324882850571
413,WP_PENTOSE_PHOSPHATE_PATHWAY_IN_SENESCENT_CELLS,7,Down,0.483681572231691,0.951324882850571
414,WP_IMMUNE_RESPONSE_TO_TUBERCULOSIS,22,Down,0.484913830837854,0.951324882850571
415,WP_SOMITOGENESIS_IN_THE_CONTEXT_OF_SPONDYLOCOSTAL_DYSOSTOSIS,2,Down,0.486256972928516,0.951324882850571
416,WP_LEPTIN_SIGNALING,69,Down,0.487071123806263,0.951324882850571
417,WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS,41,Down,0.48843327136199,0.951324882850571
418,WP_OVERVIEW_OF_NANOPARTICLE_EFFECTS,13,Down,0.488836284549915,0.951324882850571
419,WP_FOXP3_IN_COVID19,9,Up,0.48929268637414,0.951324882850571
420,WP_MRNA_VACCINE_ACTIVATION_OF_DENDRITIC_CELL_AND_INDUCTION_OF_IFN1,7,Down,0.492287745406568,0.951324882850571
421,WP_NODLIKE_RECEPTOR_NLR_SIGNALING,8,Down,0.493120340962965,0.951324882850571
422,WP_EXTRAFOLLICULAR_AND_FOLLICULAR_B_CELL_ACTIVATION_BY_SARSCOV2,40,Up,0.493353225518691,0.951324882850571
423,WP_B_CELL_RECEPTOR_SIGNALING,83,Up,0.494473565066967,0.951324882850571
424,WP_CALORIC_RESTRICTION_AND_AGING,7,Up,0.495269070171078,0.951324882850571
425,WP_FERROPTOSIS,49,Up,0.49535849584386,0.951324882850571
426,WP_NEPHROTIC_SYNDROME,28,Down,0.495872911870202,0.951324882850571
427,WP_ENDOPLASMIC_RETICULUM_STRESS_RESPONSE_IN_CORONAVIRUS_INFECTION,34,Down,0.49639053031862,0.951324882850571
428,WP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS,16,Up,0.497292121822602,0.951324882850571
429,WP_SCFA_AND_SKELETAL_MUSCLE_SUBSTRATE_METABOLISM,2,Up,0.497866696730344,0.951324882850571
430,WP_VITAMIN_B12_DISORDERS,9,Down,0.501166817621625,0.951324882850571
431,WP_SOMATROPH_AXIS_GH_AND_ITS_RELATIONSHIP_TO_DIETARY_RESTRICTION_AND_AGING,6,Up,0.501387155520991,0.951324882850571
432,WP_LUNG_FIBROSIS,31,Down,0.502732644876861,0.951324882850571
433,WP_WNTBETACATENIN_SIGNALING_IN_LEUKEMIA,10,Up,0.503808782413361,0.951324882850571
434,WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY,15,Up,0.505838599198712,0.951324882850571
435,WP_REGULATION_OF_ACTIN_CYTOSKELETON,89,Up,0.506345847596937,0.951324882850571
436,WP_NEOVASCULARIZATION_PROCESSES,21,Down,0.507213285842424,0.951324882850571
437,WP_PATHOGENESIS_OF_SARSCOV2_MEDIATED_BY_NSP9NSP10_COMPLEX,9,Down,0.507854978969257,0.951324882850571
438,WP_THYROID_HORMONES_PRODUCTION_AND_PERIPHERAL_DOWNSTREAM_SIGNALING_EFFECTS,55,Up,0.508619238141152,0.951324882850571
439,WP_MODULATION_OF_PI3KAKTMTOR_SIGNALING_BY_BIOACTIVE_SPHINGOLIPIDS,10,Up,0.509593938947603,0.951324882850571
440,WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV,12,Up,0.510525729628998,0.951324882850571
441,WP_METABOLISM_OF_ALPHALINOLENIC_ACID,3,Up,0.513822119107061,0.951324882850571
442,WP_STEROL_REGULATORY_ELEMENTBINDING_PROTEINS_SREBP_SIGNALING,64,Up,0.513968056263168,0.951324882850571
443,WP_CATALYTIC_CYCLE_OF_MAMMALIAN_FLAVINCONTAINING_MONOOXYGENASES_FMOS,2,Up,0.514407370689713,0.951324882850571
444,WP_MELANOMA,53,Down,0.514538145648341,0.951324882850571
445,WP_DNA_MISMATCH_REPAIR,21,Down,0.515011645825431,0.951324882850571
446,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_APOPTOSIS,19,Down,0.51747998186048,0.952209509742657
447,WP_TCELL_RECEPTOR_SIGNALING,71,Down,0.518344075854972,0.952209509742657
448,WP_DISORDERS_OF_FOLATE_METABOLISM_AND_TRANSPORT,15,Down,0.520116408326093,0.952209509742657
449,WP_TAMOXIFEN_METABOLISM,2,Up,0.520124172596658,0.952209509742657
450,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_DIABETIC_CONDITION,6,Up,0.52466733199015,0.95494708935479
451,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_NORMAL_CONDITION,6,Up,0.52466733199015,0.95494708935479
452,WP_MIRNA_REGULATION_OF_P53_PATHWAY_IN_PROSTATE_CANCER,20,Down,0.525104725533291,0.95494708935479
453,WP_CILIOPATHIES,120,Up,0.527872849469902,0.956636152314631
454,WP_IL4_SIGNALING,50,Up,0.528918500655619,0.956636152314631
455,WP_ANGIOGENESIS,13,Down,0.529524877497758,0.956636152314631
456,WP_CHEMOKINE_SIGNALING,106,Up,0.535960894724004,0.966140033910376
457,WP_LEUCINE_ISOLEUCINE_AND_VALINE_METABOLISM,23,Up,0.540003760839782,0.969990828190134
458,WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS,15,Up,0.541540298180808,0.969990828190134
459,WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION,33,Up,0.543419913799667,0.969990828190134
460,WP_CHOLESTEROL_BIOSYNTHESIS_WITH_SKELETAL_DYSPLASIAS,6,Up,0.545583867556072,0.969990828190134
461,WP_FOCAL_ADHESION,115,Down,0.54691999997786,0.969990828190134
462,WP_WNTBETACATENIN_SIGNALING_INHIBITORS_IN_CURRENT_AND_PAST_CLINICAL_TRIALS,3,Down,0.548062404433428,0.969990828190134
463,WP_TCELL_ANTIGEN_RECEPTOR_TCR_PATHWAY_DURING_STAPHYLOCOCCUS_AUREUS_INFECTION,43,Down,0.549505143639207,0.969990828190134
464,WP_HEPATOCYTE_GROWTH_FACTOR_RECEPTOR_SIGNALING,31,Down,0.550715970436418,0.969990828190134
465,WP_OXYSTEROLS_DERIVED_FROM_CHOLESTEROL,18,Up,0.552424143317069,0.969990828190134
466,WP_CANNABINOID_RECEPTOR_SIGNALING,16,Up,0.553340857296494,0.969990828190134
467,WP_CONVERSION_OF_ANGIOTENSINOGEN_TO_ANGIOTENSIN_II,2,Down,0.55449326828934,0.969990828190134
468,WP_FLUOROACETIC_ACID_TOXICITY,6,Down,0.55451689707308,0.969990828190134
469,WP_MONOAMINE_GPCRS,3,Up,0.55451836264886,0.969990828190134
470,WP_AFFECTED_PATHWAYS_IN_DUCHENNE_MUSCULAR_DYSTROPHY,39,Down,0.557519703393055,0.969990828190134
471,WP_GANGLIO_SERIES_SPHINGOLIPID_METABOLISM,8,Down,0.557921682716035,0.969990828190134
472,WP_NOTCH_SIGNALING_WP61,47,Down,0.559881919938288,0.969990828190134
473,WP_METABOLIC_EPILEPTIC_DISORDERS,54,Down,0.560245487046397,0.969990828190134
474,WP_MFAP5MEDIATED_OVARIAN_CANCER_CELL_MOTILITY_AND_INVASIVENESS,7,Down,0.563767952958734,0.969990828190134
475,WP_IL1_AND_MEGAKARYOCYTES_IN_OBESITY,17,Up,0.56574420597026,0.969990828190134
476,WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION,28,Up,0.566068029434854,0.969990828190134
477,WP_PLURIPOTENT_STEM_CELL_DIFFERENTIATION_PATHWAY,10,Down,0.566285803648303,0.969990828190134
478,WP_MATRIX_METALLOPROTEINASES,7,Down,0.566877086960267,0.969990828190134
479,WP_SUPPRESSION_OF_HMGB1MEDIATED_INFLAMMATION_BY_THBD,9,Down,0.567672651868012,0.969990828190134
480,WP_MFAP5_EFFECT_ON_PERMEABILITY_AND_MOTILITY_OF_ENDOTHELIAL_CELLS_VIA_CYTOSKELETON_REARRANGEMENT,11,Down,0.568023922943651,0.969990828190134
481,WP_RUBINSTEINTAYBI_SYNDROME_1,12,Down,0.569250843538035,0.969990828190134
482,WP_OVARIAN_INFERTILITY,21,Down,0.569315483409582,0.969990828190134
483,WP_22Q112_COPY_NUMBER_VARIATION_SYNDROME,68,Down,0.573370819500899,0.969990828190134
484,WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3,55,Down,0.573439823365786,0.969990828190134
485,WP_10Q1121Q1123_COPY_NUMBER_VARIATION_SYNDROME,41,Up,0.573877268889894,0.969990828190134
486,WP_PHOSPHOINOSITIDES_METABOLISM,38,Up,0.574681159611083,0.969990828190134
487,WP_11P112_COPY_NUMBER_VARIATION_SYNDROME,37,Down,0.575618543609154,0.969990828190134
488,WP_TRYPTOPHAN_CATABOLISM_LEADING_TO_NAD_PRODUCTION,11,Up,0.577173346380123,0.969990828190134
489,WP_AMINO_ACID_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,3,Down,0.577233157412705,0.969990828190134
490,WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY,101,Down,0.579529060639833,0.969990828190134
491,WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION,29,Down,0.580936971350208,0.969990828190134
492,WP_OMEGA3_OMEGA6_FATTY_ACID_SYNTHESIS,11,Up,0.58231590555601,0.969990828190134
493,WP_SARSCOV2_AND_ACE2_RECEPTOR_MOLECULAR_MECHANISMS,1,Down,0.583014770360972,0.969990828190134
494,WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_STAGE_3_OF_3,26,Down,0.583162094612435,0.969990828190134
495,WP_TOLLLIKE_RECEPTOR_SIGNALING,79,Down,0.585838131919086,0.969990828190134
496,WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX,17,Up,0.586157332880092,0.969990828190134
497,WP_KENNEDY_PATHWAY_FROM_SPHINGOLIPIDS,12,Down,0.587217403644324,0.969990828190134
498,WP_EGFEGFR_SIGNALING,135,Down,0.587658676932709,0.969990828190134
499,WP_ANDROGEN_RECEPTOR_SIGNALING,76,Down,0.589400976668132,0.97028673608687
500,WP_PHOSPHATIDYL_INOSITOL_PHOSPHATE_PATHWAY,37,Up,0.590307502086655,0.97028673608687
501,WP_PRIMARY_OVARIAN_INSUFFICIENCY,88,Down,0.592245568697073,0.97028673608687
502,WP_TRANSSULFURATION_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS,40,Down,0.592559539556701,0.97028673608687
503,WP_PENTOSE_PHOSPHATE_METABOLISM,7,Up,0.594915733564156,0.970562119043857
504,WP_IL7_SIGNALING,23,Down,0.595773385427927,0.970562119043857
505,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5321,20,Down,0.597365343672222,0.970562119043857
506,WP_COHESIN_COMPLEX_CORNELIA_DE_LANGE_SYNDROME,26,Down,0.597450647489284,0.970562119043857
507,WP_CELL_DIFFERENTIATION_INDEX,7,Up,0.608840971460598,0.974170509283448
508,WP_MEVALONATE_PATHWAY,7,Up,0.610835155182774,0.974170509283448
509,WP_ALANINE_AND_ASPARTATE_METABOLISM,5,Up,0.61299217586069,0.974170509283448
510,WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS,58,Up,0.613419325617108,0.974170509283448
511,WP_FATTY_ACID_BETAOXIDATION,28,Up,0.615333826426627,0.974170509283448
512,WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE,11,Down,0.615974682345419,0.974170509283448
513,WP_REGULATION_OF_APOPTOSIS_BY_PARATHYROID_HORMONERELATED_PROTEIN,20,Up,0.616212241325268,0.974170509283448
514,WP_CHOLESTEROL_METABOLISM,48,Up,0.616577557997212,0.974170509283448
515,WP_TROP2_REGULATORY_SIGNALING,41,Up,0.619847141119114,0.974170509283448
516,WP_KYNURENINE_PATHWAY_AND_LINKS_TO_CELL_SENESCENCE,14,Down,0.620529175710725,0.974170509283448
517,WP_FACTORS_AND_PATHWAYS_AFFECTING_INSULINLIKE_GROWTH_FACTOR_IGF1AKT_SIGNALING,28,Up,0.621393168200093,0.974170509283448
518,WP_GENES_RELATED_TO_PRIMARY_CILIUM_DEVELOPMENT_BASED_ON_CRISPR,87,Down,0.621611730368209,0.974170509283448
519,WP_METHIONINE_METABOLISM_LEADING_TO_SULFUR_AMINO_ACIDS_AND_RELATED_DISORDERS,5,Up,0.621747182473941,0.974170509283448
520,WP_MAPK_AND_NFKB_SIGNALING_INHIBITED_BY_YERSINIA_YOPJ,12,Up,0.62338263535014,0.974170509283448
521,WP_NCRNAS_INVOLVED_IN_STAT3_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,10,Up,0.624903841767971,0.974170509283448
522,WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA,32,Down,0.629780304140594,0.974170509283448
523,WP_NANOPARTICLE_TRIGGERED_REGULATED_NECROSIS,12,Down,0.63093947207345,0.974170509283448
524,WP_SRF_AND_MIRS_IN_SMOOTH_MUSCLE_DIFFERENTIATION_AND_PROLIFERATION,9,Up,0.632437134759946,0.974170509283448
525,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_AUTOPHAGY,19,Up,0.632548854607786,0.974170509283448
526,WP_BIOMARKERS_FOR_UREA_CYCLE_DISORDERS,2,Down,0.632763946747804,0.974170509283448
527,WP_FOLATE_METABOLISM,36,Down,0.63326870892413,0.974170509283448
528,WP_ALPHA_6_BETA_4_SIGNALING,26,Down,0.634346410446195,0.974170509283448
529,WP_INTERFERON_TYPE_I_SIGNALING,50,Down,0.634362989675698,0.974170509283448
530,WP_4HYDROXYTAMOXIFEN_DEXAMETHASONE_AND_RETINOIC_ACIDS_REGULATION_OF_P27_EXPRESSION,24,Down,0.635591396476401,0.974170509283448
531,WP_RETT_SYNDROME,29,Up,0.637701781179149,0.974170509283448
532,WP_LEUKOTRIENE_METABOLIC_PATHWAY,8,Down,0.63832630126756,0.974170509283448
533,WP_WNT_SIGNALING_AND_PLURIPOTENCY,56,Up,0.638796665260666,0.974170509283448
534,WP_TRIACYLGLYCERIDE_SYNTHESIS,17,Down,0.641453135076441,0.974170509283448
535,WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,51,Down,0.643074163669129,0.974170509283448
536,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5122,19,Down,0.643969754797776,0.974170509283448
537,WP_GLP1_IN_PANCREATIC_ISLET_CELLS,1,Down,0.645799303765863,0.974170509283448
538,WP_SLEEP_REGULATION,10,Up,0.647197559001993,0.974170509283448
539,WP_HIPPOCAMPAL_SYNAPTOGENESIS_AND_NEUROGENESIS,12,Down,0.64740275724708,0.974170509283448
540,WP_NUCLEOTIDE_EXCISION_REPAIR,43,Down,0.649943318137853,0.974170509283448
541,WP_OSTEOPONTIN_SIGNALING,11,Down,0.652327772342172,0.974170509283448
542,WP_NAD_METABOLISM,12,Down,0.652506504564141,0.974170509283448
543,WP_PAFAH1B1_COPY_NUMBER_VARIATION,9,Down,0.653429566570328,0.974170509283448
544,WP_MIR124_PREDICTED_INTERACTIONS_WITH_CELL_CYCLE_AND_DIFFERENTIATION,5,Up,0.653509905124143,0.974170509283448
545,WP_GLYOXYLATE_METABOLISM,5,Down,0.654783026906244,0.974170509283448
546,WP_ENDOTHELIN_PATHWAYS,10,Up,0.655313142267804,0.974170509283448
547,WP_MALE_INFERTILITY,65,Down,0.655991514812472,0.974170509283448
548,WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE,4,Down,0.656080360251391,0.974170509283448
549,WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION,25,Down,0.65869217084202,0.974170509283448
550,WP_NONCLASSICAL_ROLE_OF_VITAMIN_D,2,Down,0.660252169468521,0.974170509283448
551,WP_MARKERS_OF_KIDNEY_CELL_LINEAGE,14,Up,0.660962747549759,0.974170509283448
552,WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,41,Down,0.661089004936221,0.974170509283448
553,WP_4P163_COPY_NUMBER_VARIATION,21,Up,0.66321594922257,0.974170509283448
554,WP_GPCRS_CLASS_A_RHODOPSINLIKE,38,Up,0.664163663500485,0.974170509283448
555,WP_AMPACTIVATED_PROTEIN_KINASE_SIGNALING,51,Up,0.664450691004023,0.974170509283448
556,WP_CHOLESTEROL_SYNTHESIS_DISORDERS,16,Up,0.664496243616486,0.974170509283448
557,WP_BIOGENIC_AMINE_SYNTHESIS,1,Up,0.66522012996205,0.974170509283448
558,WP_NEUROTRANSMITTER_DISORDERS,1,Up,0.66522012996205,0.974170509283448
559,WP_EDA_SIGNALING_IN_HAIR_FOLLICLE_DEVELOPMENT,3,Down,0.666543822294294,0.974170509283448
560,WP_REGULATION_OF_WNT_BCATENIN_SIGNALING_BY_SMALL_MOLECULE_COMPOUNDS,12,Down,0.668695924599054,0.974170509283448
561,WP_TRANSCRIPTIONAL_CASCADE_REGULATING_ADIPOGENESIS,10,Up,0.669010069126316,0.974170509283448
562,WP_BDNFTRKB_SIGNALING,26,Down,0.67080457400666,0.974170509283448
563,WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA,59,Down,0.671313331733429,0.974170509283448
564,WP_PDGFRBETA_PATHWAY,26,Down,0.672210114584662,0.974170509283448
565,WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES,266,Up,0.674466530596024,0.974170509283448
566,WP_GASTRIC_CANCER_NETWORK_2,24,Up,0.674861386087811,0.974170509283448
567,WP_7OXOC_AND_7BETAHC_PATHWAYS,16,Up,0.675833115303967,0.974170509283448
568,WP_VITAMIN_A_AND_CAROTENOID_METABOLISM,19,Down,0.676653057681063,0.974170509283448
569,WP_AFLATOXIN_B1_METABOLISM,2,Up,0.677353136962135,0.974170509283448
570,WP_LET7_INHIBITION_OF_ES_CELL_REPROGRAMMING,3,Down,0.679306978723861,0.974170509283448
571,WP_VITAMIN_A1_AND_A5X_PATHWAYS,3,Up,0.681191817613328,0.974170509283448
572,WP_NETRINUNC5B_SIGNALING,35,Down,0.681699815783354,0.974170509283448
573,WP_ATM_SIGNALING_IN_DEVELOPMENT_AND_DISEASE,43,Up,0.682885507271209,0.974170509283448
574,WP_NRP1TRIGGERED_SIGNALING_IN_PANCREATIC_CANCER,32,Up,0.683806758722557,0.974170509283448
575,WP_MAPK_PATHWAY_IN_CONGENITAL_THYROID_CANCER,14,Down,0.68403903780906,0.974170509283448
576,WP_LNCRNAMEDIATED_MECHANISMS_OF_THERAPEUTIC_RESISTANCE,4,Up,0.684861256266833,0.974170509283448
577,WP_TYPE_II_DIABETES_MELLITUS,14,Down,0.685121386923731,0.974170509283448
578,WP_TCA_CYCLE_NUTRIENT_USE_AND_INVASIVENESS_OF_OVARIAN_CANCER,4,Up,0.687979224984551,0.974170509283448
579,WP_MAMMARY_GLAND_DEVELOPMENT_EMBRYONIC_DEVELOPMENT_STAGE_1_OF_4,7,Up,0.68809107275364,0.974170509283448
580,WP_NEUROGENESIS_REGULATION_IN_THE_OLFACTORY_EPITHELIUM,29,Up,0.690598009329963,0.974170509283448
581,WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE,15,Up,0.693209706269163,0.974170509283448
582,WP_RAC1PAK1P38MMP2_PATHWAY,50,Down,0.693614008655925,0.974170509283448
583,WP_SYNAPTIC_SIGNALING_ASSOCIATED_WITH_AUTISM_SPECTRUM_DISORDER,34,Down,0.696396074443099,0.974170509283448
584,WP_MAMMALIAN_DISORDER_OF_SEXUAL_DEVELOPMENT,2,Down,0.696624945217225,0.974170509283448
585,WP_CANCER_IMMUNOTHERAPY_BY_PD1_BLOCKADE,14,Up,0.696842562332572,0.974170509283448
586,WP_KININKALLIKREIN_PATHWAY,2,Down,0.697340065727538,0.974170509283448
587,WP_GPCRS_OTHER,11,Up,0.699234561502635,0.974170509283448
588,WP_OMEGA6FATTY_ACIDS_IN_SENESCENCE,31,Up,0.701746354321869,0.974170509283448
589,WP_CYSTEINE_AND_METHIONINE_CATABOLISM,10,Up,0.702985272123596,0.974170509283448
590,WP_MITOCHONDRIAL_FATTY_ACID_OXIDATION_DISORDERS,18,Down,0.703510619502457,0.974170509283448
591,WP_NANOPARTICLEMEDIATED_ACTIVATION_OF_RECEPTOR_SIGNALING,22,Down,0.704903799543343,0.974170509283448
592,WP_IL2_SIGNALING,37,Up,0.704941239813105,0.974170509283448
593,WP_TYPE_III_INTERFERON_SIGNALING,7,Down,0.705336627606841,0.974170509283448
594,WP_CANONICAL_NFKB_PATHWAY,8,Up,0.706595830067418,0.974170509283448
595,WP_GANGLIO_SPHINGOLIPID_METABOLISM,6,Down,0.707648727202331,0.974170509283448
596,WP_INFLAMMATORY_BOWEL_DISEASE_SIGNALING,23,Up,0.708720476717255,0.974170509283448
597,WP_GLYCEROLIPIDS_AND_GLYCEROPHOSPHOLIPIDS,21,Down,0.70896625823407,0.974170509283448
598,WP_CANONICAL_AND_NONCANONICAL_TGFB_SIGNALING,11,Up,0.710177936488298,0.974170509283448
599,WP_MACROPHAGE_MARKERS,8,Up,0.711878429362728,0.974170509283448
600,WP_FRAGILE_X_SYNDROME,83,Down,0.712245387450671,0.974170509283448
601,WP_NPHP1_DELETION_SYNDROME,10,Up,0.712258486714541,0.974170509283448
602,WP_ALLOGRAFT_REJECTION,50,Up,0.715892176906012,0.977513902685617
603,WP_GLYCINE_METABOLISM_INCLUDING_IMDS,14,Down,0.722089730845521,0.983917041118759
604,WP_KIT_RECEPTOR_SIGNALING,49,Up,0.723117813082709,0.983917041118759
605,WP_WNT_SIGNALING_WP428,57,Down,0.724491904352734,0.983917041118759
606,WP_TH17_CELL_DIFFERENTIATION_PATHWAY,46,Down,0.726334842300025,0.983917041118759
607,WP_PLEURAL_MESOTHELIOMA,242,Down,0.731466994747327,0.983917041118759
608,WP_MICRORNA_NETWORK_ASSOCIATED_WITH_CHRONIC_LYMPHOCYTIC_LEUKEMIA,4,Up,0.731796130526746,0.983917041118759
609,WP_TGIF_DISRUPTION_OF_SHH_SIGNALING,3,Down,0.731910419213699,0.983917041118759
610,WP_CELL_DIFFERENTIATION_EXPANDED_INDEX,11,Up,0.732467807037174,0.983917041118759
611,WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM,12,Down,0.738330092648701,0.983917041118759
612,WP_MAPK_SIGNALING,160,Down,0.738905777873134,0.983917041118759
613,WP_CORI_CYCLE,11,Down,0.738962913766298,0.983917041118759
614,WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS,72,Down,0.741039484039516,0.983917041118759
615,WP_NEURODEGENERATION_WITH_BRAIN_IRON_ACCUMULATION_NBIA_SUBTYPES_PATHWAY,41,Down,0.745265739648806,0.983917041118759
616,WP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,27,Up,0.74766210416123,0.983917041118759
617,WP_BLADDER_CANCER,28,Down,0.747817938600302,0.983917041118759
618,WP_ARYLAMINE_METABOLISM,1,Up,0.748056429558938,0.983917041118759
619,WP_DNA_REPAIR_PATHWAYS_FULL_NETWORK,112,Down,0.749504686503506,0.983917041118759
620,WP_DISORDERS_IN_KETONE_BODY_SYNTHESIS,2,Down,0.749877066322485,0.983917041118759
621,WP_NUCLEOTIDE_GPCRS,6,Up,0.751153497688722,0.983917041118759
622,WP_ROS_IN_COVID19_ENDOTHELIAL_DYSFUNCTION,5,Up,0.751834378029065,0.983917041118759
623,WP_ONECARBON_METABOLISM,22,Down,0.752453951840605,0.983917041118759
624,WP_TP53_NETWORK,16,Up,0.754833986177893,0.983917041118759
625,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY_IN_HEPATOCYTES,62,Down,0.755699254338877,0.983917041118759
626,WP_IL3_SIGNALING,46,Up,0.755791609178817,0.983917041118759
627,WP_ERBB_SIGNALING,66,Down,0.757334711002276,0.983917041118759
628,WP_PURINERGIC_SIGNALING,14,Up,0.757843485705137,0.983917041118759
629,WP_ATM_SIGNALING,33,Down,0.757941784207357,0.983917041118759
630,WP_IL5_SIGNALING,37,Up,0.758088896469319,0.983917041118759
631,WP_1Q211_COPY_NUMBER_VARIATION_SYNDROME,14,Up,0.758388377490594,0.983917041118759
632,WP_OXIDATIVE_STRESS_RESPONSE,21,Up,0.761139505947824,0.983917041118759
633,WP_NSP1_FROM_SARSCOV2_INHIBITS_TRANSLATION_INITIATION_IN_THE_HOST_CELL,16,Up,0.761995703624867,0.983917041118759
634,WP_RESOLVIN_E1_AND_RESOLVIN_D1_SIGNALING_DECREASE_INFLAMMATION,9,Down,0.763238846373698,0.983917041118759
635,WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION,19,Down,0.764952112530187,0.983917041118759
636,WP_TRANSLATION_INHIBITORS_IN_CHRONICALLY_ACTIVATED_PDGFRA_CELLS,45,Down,0.765271089909188,0.983917041118759
637,WP_HDAC6_INTERACTIONS_IN_THE_CENTRAL_NERVOUS_SYSTEM,85,Down,0.766353763822682,0.983917041118759
638,WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY,24,Up,0.767113256571909,0.983917041118759
639,WP_ASPIRIN_AND_MIRNAS,8,Up,0.76933588126569,0.983917041118759
640,WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER,46,Up,0.772917058630569,0.983917041118759
641,WP_ADHD_AND_AUTISM_ASD_PATHWAYS,167,Up,0.772995011239611,0.983917041118759
642,WP_DNA_IRDOUBLE_STRAND_BREAKS_AND_CELLULAR_RESPONSE_VIA_ATM,48,Up,0.773074776433,0.983917041118759
643,WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA,25,Down,0.774502294151162,0.983917041118759
644,WP_FATTY_ACID_TRANSPORTERS,10,Down,0.775229018116935,0.983917041118759
645,WP_UREA_CYCLE_AND_METABOLISM_OF_AMINO_GROUPS,9,Down,0.776785181968221,0.983917041118759
646,WP_ENDOCHONDRAL_OSSIFICATION,26,Down,0.781404456899971,0.983917041118759
647,WP_ENDOCHONDRAL_OSSIFICATION_WITH_SKELETAL_DYSPLASIAS,26,Down,0.781404456899971,0.983917041118759
648,WP_PYRIMIDINE_METABOLISM_AND_RELATED_DISEASES,13,Down,0.781687473579819,0.983917041118759
649,WP_KCNQ2RELATED_EPILEPSIES,11,Up,0.783200417985729,0.983917041118759
650,WP_NEURAL_CREST_DIFFERENTIATION,35,Down,0.784881681285586,0.983917041118759
651,WP_15Q25_COPY_NUMBER_VARIATION,28,Up,0.787947852620286,0.983917041118759
652,WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS,36,Up,0.789211404674705,0.983917041118759
653,WP_IL9_SIGNALING,15,Up,0.789518731510015,0.983917041118759
654,WP_EPO_RECEPTOR_SIGNALING,23,Up,0.790234768738951,0.983917041118759
655,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_PATHWAY,5,Up,0.79139468070803,0.983917041118759
656,WP_NETWORK_MAP_OF_SARSCOV2_SIGNALING,133,Down,0.791573184983387,0.983917041118759
657,WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR,70,Up,0.792339816135359,0.983917041118759
658,WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS,86,Up,0.792690002987585,0.983917041118759
659,WP_P53_TRANSCRIPTIONAL_GENE_NETWORK,64,Down,0.796853012511479,0.983917041118759
660,WP_IL19_SIGNALING,20,Down,0.797428107469858,0.983917041118759
661,WP_MIRNA_REGULATION_OF_PROSTATE_CANCER_SIGNALING,26,Up,0.799531515881953,0.983917041118759
662,WP_GLIOBLASTOMA_SIGNALING,64,Down,0.799570368007123,0.983917041118759
663,WP_BLOOD_CLOTTING_CASCADE,5,Up,0.802580808726156,0.983917041118759
664,WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT,6,Up,0.804502456543963,0.983917041118759
665,WP_METABOLIC_REPROGRAMMING_IN_PANCREATIC_CANCER,35,Down,0.805424623379771,0.983917041118759
666,WP_ARSENIC_METABOLISM_AND_REACTIVE_OXYGEN_SPECIES_GENERATION,9,Down,0.806850920220002,0.983917041118759
667,WP_ANDROGEN_RECEPTOR_NETWORK_IN_PROSTATE_CANCER,84,Down,0.80725245955135,0.983917041118759
668,WP_EFFECTS_OF_MFN2_MUTATION,17,Down,0.808725997514766,0.983917041118759
669,WP_PANCREATIC_CANCER_SUBTYPES,5,Up,0.808869824088225,0.983917041118759
670,WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY,14,Down,0.809960339825002,0.983917041118759
671,WP_VITAMIN_B12_METABOLISM,23,Up,0.812440625473726,0.983917041118759
672,WP_TRYPTOPHAN_METABOLISM,17,Up,0.819081215025905,0.983917041118759
673,WP_SMALL_LIGAND_GPCRS,7,Up,0.819917829121006,0.983917041118759
674,WP_AMINO_ACID_METABOLISM,57,Down,0.823060234623228,0.983917041118759
675,WP_PROLINE_AND_HYDROXYPROLINE_PATHWAYS,3,Down,0.82445096834384,0.983917041118759
676,WP_JAKSTAT_SIGNALING_IN_THE_REGULATION_OF_BETA_CELLS,26,Up,0.824615044936725,0.983917041118759
677,WP_MALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,4,Down,0.825175992862426,0.983917041118759
678,WP_BURN_WOUND_HEALING,57,Up,0.825462055972075,0.983917041118759
679,WP_ESTROGEN_SIGNALING,21,Down,0.825989491645577,0.983917041118759
680,WP_AMINO_ACID_METABOLISM_PATHWAY_EXCERPT_HISTIDINE_CATABOLISM_EXTENSION,2,Down,0.829255451279767,0.983917041118759
681,WP_RAS_SIGNALING,113,Down,0.830113329414953,0.983917041118759
682,WP_MODULATORS_OF_TCR_SIGNALING_AND_T_CELL_ACTIVATION,47,Up,0.831165708664694,0.983917041118759
683,WP_PATHOPHYSIOLOGICAL_ROLES_OF_DUX4_IN_FSHD1,7,Up,0.833886199710851,0.983917041118759
684,WP_MIR517_RELATIONSHIP_WITH_ARCN1_AND_USP1,4,Up,0.835279876790167,0.983917041118759
685,WP_MITOCHONDRIAL_COMPLEX_II_ASSEMBLY,8,Down,0.835411937590549,0.983917041118759
686,WP_WNT_SIGNALING_WP363,36,Down,0.836334351596253,0.983917041118759
687,WP_PTF1A_RELATED_REGULATORY_PATHWAY,5,Down,0.839118473331976,0.983917041118759
688,WP_P38_MAPK_SIGNALING,31,Down,0.83976259886263,0.983917041118759
689,WP_TCA_CYCLE_AND_DEFICIENCY_OF_PYRUVATE_DEHYDROGENASE_COMPLEX_PDHC,15,Down,0.839896924135648,0.983917041118759
690,WP_HEART_DEVELOPMENT,15,Up,0.839983044686608,0.983917041118759
691,WP_15Q133_COPY_NUMBER_VARIATION_SYNDROME,9,Down,0.840376142473396,0.983917041118759
692,WP_ETHANOL_EFFECTS_ON_HISTONE_MODIFICATIONS,24,Down,0.840872004934707,0.983917041118759
693,WP_10Q22Q23_COPY_NUMBER_VARIATION,27,Down,0.8409568275763,0.983917041118759
694,WP_ACETYLCHOLINE_SYNTHESIS,4,Down,0.841584808186218,0.983917041118759
695,WP_ESTRADIOL_REGULATION_IN_PORTOSINUSOIDAL_VASCULAR_DISEASE,4,Down,0.842433188757179,0.983917041118759
696,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_AND_RESPIRATION,11,Up,0.846352847298364,0.983917041118759
697,WP_ARACHIDONATE_EPOXYGENASE_EPOXIDE_HYDROLASE,3,Down,0.846612478151937,0.983917041118759
698,WP_GPR40_PATHWAY,8,Down,0.846836174509516,0.983917041118759
699,WP_SMC1SMC3_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,11,Down,0.847584912430641,0.983917041118759
700,WP_MITOCHONDRIAL_IMMUNE_RESPONSE_TO_SARSCOV2,23,Up,0.848524653617374,0.983917041118759
701,WP_GPCRS_CLASS_B_SECRETINLIKE,3,Down,0.849302193983354,0.983917041118759
702,WP_TGFBETA_RECEPTOR_SIGNALING,34,Up,0.84989768295877,0.983917041118759
703,WP_EPAC1_AND_PKA_REDUCTION_OF_RETINAL_INFLAMMATION,8,Up,0.849954626509887,0.983917041118759
704,WP_GAMMAGLUTAMYL_CYCLE_FOR_THE_BIOSYNTHESIS_AND_DEGRADATION_OF_GLUTATHIONE_INCLUDING_DISEASES,4,Up,0.850555539883605,0.983917041118759
705,WP_VEGFAVEGFR2_SIGNALING,331,Up,0.853468245719216,0.983917041118759
706,WP_WARBURG_EFFECT_MODULATED_BY_DEUBIQUITINATING_ENZYMES_AND_THEIR_SUBSTRATES,21,Down,0.853671567640008,0.983917041118759
707,WP_BASE_EXCISION_REPAIR,29,Up,0.854718540270605,0.983917041118759
708,WP_CELLULAR_PROTEOSTASIS,6,Down,0.85620390954628,0.983917041118759
709,WP_TRANSLATION_FACTORS,49,Down,0.857584160495391,0.983917041118759
710,WP_NEPHROGENESIS,4,Down,0.857730546648158,0.983917041118759
711,WP_PRADERWILLI_AND_ANGELMAN_SYNDROME,62,Up,0.85814481212205,0.983917041118759
712,WP_IL18_SIGNALING,184,Up,0.861522472756548,0.983917041118759
713,WP_T_CELL_MODULATION_IN_PANCREATIC_CANCER,21,Up,0.862431045855972,0.983917041118759
714,WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX,15,Down,0.862725968242499,0.983917041118759
715,WP_IL6_SIGNALING,39,Up,0.864576560171162,0.983917041118759
716,WP_MITOCHONDRIAL_LONG_CHAIN_FATTY_ACID_BETAOXIDATION,16,Down,0.865522366090827,0.983917041118759
717,WP_ACUTE_VIRAL_MYOCARDITIS,63,Down,0.866110417166928,0.983917041118759
718,WP_ETHER_LIPID_BIOSYNTHESIS,16,Up,0.869393734334121,0.983917041118759
719,WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE,59,Down,0.870438653563301,0.983917041118759
720,WP_HEMESYNTHESIS_DEFECTS_AND_PORPHYRIAS,8,Down,0.870504303841851,0.983917041118759
721,WP_HEME_BIOSYNTHESIS,8,Down,0.870504303841851,0.983917041118759
722,WP_IL11_SIGNALING,40,Up,0.870987920169997,0.983917041118759
723,WP_SMITHMAGENIS_AND_POTOCKILUPSKI_SYNDROME_COPY_NUMBER_VARIATION,122,Up,0.872246285538953,0.983917041118759
724,WP_REGULATORY_CIRCUITS_OF_STAT3_SIGNALING,47,Down,0.872361340944128,0.983917041118759
725,WP_BILE_ACID_SYNTHESIS_AND_ENTEROHEPATIC_CIRCULATION,3,Up,0.877246066709751,0.983917041118759
726,WP_PI3KAKT_SIGNALING,172,Up,0.879884680244418,0.983917041118759
727,WP_FAMILIAL_PARTIAL_LIPODYSTROPHY,22,Up,0.879951342971401,0.983917041118759
728,WP_LACTATE_SHUTTLE_IN_GLIAL_CELLS,8,Up,0.879957309793787,0.983917041118759
729,WP_16P112_PROXIMAL_DELETION_SYNDROME,61,Down,0.881485196148156,0.983917041118759
730,WP_CREATINE_PATHWAY,1,Down,0.883829672600931,0.983917041118759
731,WP_CANCER_PATHWAYS,292,Down,0.887256604555227,0.983917041118759
732,WP_GLYCOLYSIS_IN_SENESCENCE,10,Down,0.887506290910583,0.983917041118759
733,WP_TCELL_ACTIVATION_SARSCOV2,61,Up,0.888779071062755,0.983917041118759
734,WP_FOLLICLE_STIMULATING_HORMONE_FSH_SIGNALING,21,Down,0.889395542253567,0.983917041118759
735,WP_TRANSCRIPTION_FACTOR_REGULATION_IN_ADIPOGENESIS,15,Up,0.889862979194708,0.983917041118759
736,WP_TNFALPHA_SIGNALING,83,Down,0.889981263530836,0.983917041118759
737,WP_VITAMIN_K_METABOLISM_AND_ACTIVATION_OF_DEPENDENT_PROTEINS,7,Up,0.890203493314937,0.983917041118759
738,WP_HIPPO_SIGNALING_REGULATION,42,Down,0.890851784199479,0.983917041118759
739,WP_FBXL10_ENHANCEMENT_OF_MAPERK_SIGNALING_IN_DIFFUSE_LARGE_BCELL_LYMPHOMA,11,Up,0.891109328834779,0.983917041118759
740,WP_GLUTATHIONE_METABOLISM,10,Up,0.891500829226263,0.983917041118759
741,WP_7Q1123_COPY_NUMBER_VARIATION_SYNDROME,79,Up,0.891852887523027,0.983917041118759
742,WP_ACE_INHIBITOR_PATHWAY,4,Up,0.892274946139015,0.983917041118759
743,WP_MIRNAS_INVOLVED_IN_DNA_DAMAGE_RESPONSE,10,Down,0.892517167551573,0.983917041118759
744,WP_FATTY_ACID_BIOSYNTHESIS,21,Down,0.892807868063072,0.983917041118759
745,WP_HAIR_FOLLICLE_DEVELOPMENT_ORGANOGENESIS_STAGE_2_OF_3,9,Down,0.893220993685354,0.983917041118759
746,WP_IL10_ANTIINFLAMMATORY_SIGNALING,10,Down,0.89464451432269,0.983917041118759
747,WP_MRNA_PROCESSING,124,Up,0.895456477055563,0.983917041118759
748,WP_MICRORNA_FOR_TARGETING_CANCER_GROWTH_AND_VASCULARIZATION_IN_GLIOBLASTOMA,5,Down,0.897496534405568,0.983917041118759
749,WP_MYD88_DISTINCT_INPUTOUTPUT_PATHWAY,16,Up,0.898190247531813,0.983917041118759
750,WP_AXON_GUIDANCE,35,Down,0.901381422517214,0.983917041118759
751,WP_UREA_CYCLE_AND_RELATED_DISEASES,2,Down,0.901998694004954,0.983917041118759
752,WP_FARNESOID_X_RECEPTOR_PATHWAY,5,Down,0.902032414909738,0.983917041118759
753,WP_STEROID_BIOSYNTHESIS,2,Down,0.902736359433672,0.983917041118759
754,WP_PREGNANE_X_RECEPTOR_PATHWAY,13,Up,0.902977905876147,0.983917041118759
755,WP_TRANSSULFURATION_PATHWAY,8,Up,0.903719423411999,0.983917041118759
756,WP_7Q1123_DISTAL_COPY_NUMBER_VARIATION,16,Down,0.909775918362893,0.98692949835101
757,WP_MELATONIN_METABOLISM_AND_EFFECTS,18,Up,0.909837189541192,0.98692949835101
758,WP_MOLYBDENUM_COFACTOR_MOCO_BIOSYNTHESIS,3,Up,0.910283465471956,0.98692949835101
759,WP_VITAMIN_D_METABOLISM,5,Down,0.913775649795018,0.98692949835101
760,WP_JOUBERT_SYNDROME,70,Down,0.914310515501144,0.98692949835101
761,WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR,29,Down,0.91547354810234,0.98692949835101
762,WP_NUCLEOTIDEBINDING_OLIGOMERIZATION_DOMAIN_NOD_PATHWAY,37,Up,0.915958706429723,0.98692949835101
763,WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS,29,Down,0.919394606125626,0.98692949835101
764,WP_ADIPOGENESIS,82,Up,0.919442367391862,0.98692949835101
765,WP_SARSCOV2_B117_VARIANT_ANTAGONISES_INNATE_IMMUNE_ACTIVATION,7,Up,0.919664035700494,0.98692949835101
766,WP_NF1_COPY_NUMBER_VARIATION_SYNDROME,62,Down,0.919693425470649,0.98692949835101
767,WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1,21,Up,0.922122749445248,0.988246284281609
768,WP_CEREBRAL_ORGANIC_ACIDURIAS_INCLUDING_DISEASES,7,Up,0.924874113665492,0.98870937467078
769,WP_PLATELETMEDIATED_INTERACTIONS_WITH_VASCULAR_AND_CIRCULATING_CELLS,10,Down,0.924960473384222,0.98870937467078
770,WP_NANOPARTICLE_TRIGGERED_AUTOPHAGIC_CELL_DEATH,21,Down,0.926875451500487,0.989469637835585
771,WP_AMPLIFICATION_AND_EXPANSION_OF_ONCOGENIC_PATHWAYS_AS_METASTATIC_TRAITS,12,Down,0.930384179892118,0.991251389109052
772,WP_TGFB_SMAD_SIGNALING,7,Up,0.930956292447917,0.991251389109052
773,WP_CALCIUM_MEDIATED_TCELL_APOPTOSIS_INVOLVED_IN_INCLUSION_BODY_MYOSITIS,13,Up,0.933011213986104,0.991902262224607
774,WP_HEDGEHOG_SIGNALING_WP4249,24,Up,0.933980962240688,0.991902262224607
775,WP_ENTEROCYTE_CHOLESTEROL_METABOLISM,25,Down,0.9369897183101,0.992377148393207
776,WP_MAMMARY_GLAND_DEVELOPMENT_PUBERTY_STAGE_2_OF_4,8,Up,0.937931951882801,0.992377148393207
777,WP_DDX1_AS_A_REGULATORY_COMPONENT_OF_THE_DROSHA_MICROPROCESSOR,7,Down,0.938049932240294,0.992377148393207
778,WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING,163,Down,0.944730893292696,0.998160403967347
779,WP_CARDIOMYOCYTE_SIGNALING_CONVERGING_ON_TITIN,17,Up,0.947137802234425,0.998478029869206
780,WP_FLUOROPYRIMIDINE_ACTIVITY,25,Down,0.949247628287831,0.998478029869206
781,WP_TCA_CYCLE_IN_SENESCENCE,9,Up,0.951478158392567,0.998478029869206
782,WP_SULINDAC_METABOLIC_PATHWAY,2,Up,0.954057417545911,0.998478029869206
783,WP_HIF1A_AND_PPARG_REGULATION_OF_GLYCOLYSIS,7,Up,0.955988789923208,0.998478029869206
784,WP_VALPROIC_ACID_PATHWAY,8,Up,0.956294957857616,0.998478029869206
785,WP_RANKLRANK_SIGNALING,47,Up,0.956619860455067,0.998478029869206
786,WP_SENESCENCEASSOCIATED_SECRETORY_PHENOTYPE_SASP,47,Down,0.956658005244151,0.998478029869206
787,WP_HEREDITARY_LEIOMYOMATOSIS_AND_RENAL_CELL_CARCINOMA_PATHWAY,18,Down,0.957360839970331,0.998478029869206
788,WP_ESTROGEN_METABOLISM_WP697,5,Down,0.958751276999873,0.998478029869206
789,WP_CYTOSINE_METHYLATION,7,Up,0.962875546953882,0.998478029869206
790,WP_DOPAMINE_METABOLISM,7,Down,0.96302511706369,0.998478029869206
791,WP_ESTROGEN_RECEPTOR_PATHWAY,8,Up,0.968231495346614,0.998478029869206
792,WP_INHIBITION_OF_EXOSOME_BIOGENESIS_AND_SECRETION_BY_MANUMYCIN_A_IN_CRPC_CELLS,18,Down,0.968963947149367,0.998478029869206
793,WP_INTERACTIONS_BETWEEN_LOXL4_AND_OXIDATIVE_STRESS_PATHWAY,12,Down,0.97196300386241,0.998478029869206
794,WP_NRF2ARE_REGULATION,20,Down,0.973033611203355,0.998478029869206
795,WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,46,Down,0.973485483799722,0.998478029869206
796,WP_MEVALONATE_ARM_OF_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,12,Down,0.975356983196826,0.998478029869206
797,WP_IRONSULFUR_CLUSTER_BIOGENESIS,15,Up,0.976312565620996,0.998478029869206
798,WP_PRION_DISEASE_PATHWAY,27,Down,0.977108935316013,0.998478029869206
799,WP_NONHOMOLOGOUS_END_JOINING,10,Up,0.977549798346963,0.998478029869206
800,WP_EXTRACELLULAR_VESICLES_IN_THE_CROSSTALK_OF_CARDIAC_CELLS,11,Up,0.980216865814958,0.998478029869206
801,WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT,82,Down,0.980554700511196,0.998478029869206
802,WP_INTERACTIONS_OF_NATURAL_KILLER_CELLS_IN_PANCREATIC_CANCER,14,Up,0.981913880574856,0.998478029869206
803,WP_AEROBIC_GLYCOLYSIS,9,Down,0.982089261481846,0.998478029869206
804,WP_AEROBIC_GLYCOLYSIS_AUGMENTED,9,Down,0.982089261481846,0.998478029869206
805,WP_PEPTIDE_GPCRS,11,Up,0.982851807637175,0.998478029869206
806,WP_CLOCKCONTROLLED_AUTOPHAGY_IN_BONE_METABOLISM,50,Up,0.983707260887793,0.998478029869206
807,WP_CARDIAC_HYPERTROPHIC_RESPONSE,44,Down,0.984387094774978,0.998478029869206
808,WP_NONSMALL_CELL_LUNG_CANCER,57,Down,0.988064243142361,0.998478029869206
809,WP_DEGRADATION_PATHWAY_OF_SPHINGOLIPIDS_INCLUDING_DISEASES,14,Down,0.98897680742711,0.998478029869206
810,WP_PROGERIAASSOCIATED_LIPODYSTROPHY,17,Down,0.990099355179457,0.998478029869206
811,WP_MAPK_CASCADE,30,Down,0.991012668095045,0.998478029869206
812,WP_SPINA_BIFIDA,10,Up,0.991100870530921,0.998478029869206
813,WP_EXRNA_MECHANISM_OF_ACTION_AND_BIOGENESIS,6,Up,0.993056257392356,0.998478029869206
814,WP_ENDOMETRIAL_CANCER,48,Up,0.993530434986409,0.998478029869206
815,WP_15Q11Q13_COPY_NUMBER_VARIATION,31,Down,0.99443218210608,0.998478029869206
816,WP_PURINE_METABOLISM,10,Down,0.994816356073445,0.998478029869206
817,WP_SEROTONIN_AND_ANXIETY,5,Up,0.995362745410881,0.998478029869206
818,WP_8P231_COPY_NUMBER_VARIATION_SYNDROME,32,Up,0.995791134550084,0.998478029869206
819,WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS,22,Down,0.995971527266678,0.998478029869206
820,WP_TYROSINE_METABOLISM_AND_RELATED_DISORDERS,2,Up,0.9964061716985,0.998478029869206
821,WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY,29,Up,0.997263336402212,0.998478029869206
822,WP_BONE_MORPHOGENIC_PROTEIN_SIGNALING_AND_REGULATION,9,Up,0.998942537524742,0.998942537524742
